On December 2, 2024, Lisa Lavange, a Director at Simulations Plus Inc (SLP, Financial), sold 650 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 7,150 shares of the company.
Simulations Plus Inc is a company that provides software and consulting services for pharmaceutical research and development. The company specializes in simulation and modeling software that assists in drug discovery and development processes.
Over the past year, Lisa Lavange has sold a total of 3,100 shares and has not purchased any shares. The insider transaction history for Simulations Plus Inc indicates that there have been no insider buys in total over the past year, while there have been 25 insider sells during the same period.
On the day of the recent sale, shares of Simulations Plus Inc were trading at $31.88, giving the stock a market cap of $628.705 million. The company's price-earnings ratio is 63.94, which is higher than the industry median of 22.725 but lower than the company’s historical median price-earnings ratio.
With a price of $31.88 and a GF Value of $59.79, Simulations Plus Inc has a price-to-GF-Value ratio of 0.53. This suggests that the stock is significantly undervalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company’s past returns and growth, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
